Contrast-induced acute kidney injury: short- and long-term implications
- PMID: 21784279
- PMCID: PMC3143363
- DOI: 10.1016/j.semnephrol.2011.05.009
Contrast-induced acute kidney injury: short- and long-term implications
Abstract
The intravascular administration of iodine-based contrast media remains a common cause of acute kidney injury and a leading cause of iatrogenic renal disease. Past research has elucidated the principal risk factors for contrast-induced acute kidney injury (CIAKI) and helped to establish the efficacy of various interventions for the prevention of this condition. The importance of preventing CIAKI has been underscored by a growing number of studies showing strong associations of CIAKI with serious adverse short- and long-term outcomes. However, it remains unclear whether these associations are causal. This is important because considerable health care resources are used to prevent CIAKI. If CIAKI is a marker, but not a mediator, of serious adverse downstream outcomes, more judicious and selective use of preventive care may be appropriate. Moreover, with an increasing number of studies reporting the underuse of coronary angiography in patients with acute coronary syndrome and underlying chronic kidney disease, presumably in part because of a fear of CIAKI, a clear understanding of whether this condition directly results in adverse downstream outcomes is essential. Careful inspection of past studies that investigated the association of CIAKI with adverse short- and long-term events sheds light on their strengths and weaknesses and provides insight into how future research may be better able to characterize the short- and long-term implications of this iatrogenic condition.
Published by Elsevier Inc.
Figures
Similar articles
-
Contrast-induced kidney injury: how does it affect long-term cardiac mortality?J Cardiovasc Med (Hagerstown). 2017 Nov;18(11):908-915. doi: 10.2459/JCM.0000000000000543. J Cardiovasc Med (Hagerstown). 2017. PMID: 28678146
-
Short-Term High-Dose Vitamin E to Prevent Contrast Medium-Induced Acute Kidney Injury in Patients With Chronic Kidney Disease Undergoing Elective Coronary Angiography: A Randomized Placebo-Controlled Trial.J Am Heart Assoc. 2016 Mar 15;5(3):e002919. doi: 10.1161/JAHA.115.002919. J Am Heart Assoc. 2016. PMID: 27068631 Free PMC article. Clinical Trial.
-
Prevention, incidence, and outcomes of contrast-induced acute kidney injury.Arch Intern Med. 2008 Jun 23;168(12):1325-32. doi: 10.1001/archinte.168.12.1325. Arch Intern Med. 2008. PMID: 18574090 Clinical Trial.
-
Pathophysiology of Contrast-Induced Acute Kidney Injury (CIAKI).Curr Pharm Des. 2019;25(44):4642-4647. doi: 10.2174/1381612825666191210152944. Curr Pharm Des. 2019. PMID: 31820694 Review.
-
Understanding and preventing contrast-induced acute kidney injury.Nat Rev Nephrol. 2017 Mar;13(3):169-180. doi: 10.1038/nrneph.2016.196. Epub 2017 Jan 31. Nat Rev Nephrol. 2017. PMID: 28138128 Review.
Cited by
-
Mechanism of Abelmoschus manihot L. in the Treatment of Contrast-Induced Nephropathy on the Basis of Network Pharmacology Analysis.Front Nephrol. 2022 Apr 22;2:834513. doi: 10.3389/fneph.2022.834513. eCollection 2022. Front Nephrol. 2022. PMID: 37675022 Free PMC article. Review.
-
Strategies for Renal Protection in Cardiovascular Interventions.Korean Circ J. 2022 Jul;52(7):485-495. doi: 10.4070/kcj.2022.0093. Korean Circ J. 2022. PMID: 35790493 Free PMC article. Review.
-
Risk of Worsening Renal Function Following Repeated Exposures to Contrast Media During Percutaneous Coronary Interventions.J Am Heart Assoc. 2021 Sep 21;10(18):e021473. doi: 10.1161/JAHA.121.021473. Epub 2021 Sep 17. J Am Heart Assoc. 2021. PMID: 34533055 Free PMC article.
-
Physical Training Is a Potential Modifier of Risk for Contrast-Induced Acute Kidney Injury in Diabetes Mellitus.Biomed Res Int. 2020 Nov 17;2020:1830934. doi: 10.1155/2020/1830934. eCollection 2020. Biomed Res Int. 2020. PMID: 33282938 Free PMC article.
-
Stanniocalcin-1 Alleviates Contrast-Induced Acute Kidney Injury by Regulating Mitochondrial Quality Control via the Nrf2 Pathway.Oxid Med Cell Longev. 2020 Apr 12;2020:1898213. doi: 10.1155/2020/1898213. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 32318235 Free PMC article.
References
-
- Barrett BJ. Contrast nephrotoxicity. J Am Soc Nephrol. 1994;5:125–37. - PubMed
-
- Parfrey PS, Griffiths SM, Barrett BJ, et al. Contrast material–induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med. 1989;320:143–9. - PubMed
-
- Rudnick MR, Berns JS, Cohen RM, Goldfarb S. Contrast media-associated nephrotoxicity. Curr Opin Nephrol Hypertens. 1996;5:127–33. - PubMed
-
- Reddan D, Laville M, Garovic VD. Contrast-induced nephropathy and its prevention: What do we really know from evidence-based findings? J Nephrol. 2009;22:333–51. - PubMed
-
- McCullough PA. Contrast-induced acute kidney injury. J Am Coll Cardiol. 2008;51:1419–28. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
